Annual report pursuant to Section 13 and 15(d)

EQUITY (Detail Textuals 1)

v3.20.2
EQUITY (Detail Textuals 1)
1 Months Ended 12 Months Ended
Jun. 25, 2019
Warrant
$ / shares
shares
Aug. 31, 2020
USD ($)
$ / shares
shares
Aug. 31, 2019
USD ($)
$ / shares
shares
Related Party Transaction [Line Items]      
Number of units sold | shares 1,300,813    
Value for issuance of common shares | $   $ 1,977,691 $ 8,376,379
Number of shares granted during period | shares   74,000 184,000
Exercise price of warrants | $ / shares $ 6.4575    
Derivative liability | $   $ 0 $ 29,501
Intrinsic value | $   $ 0 $ 0
Number of warrant purchase | Warrant 1    
Common stock, par value (in dollars per share) | $ / shares $ 0.001 $ 0.001 $ 0.001
Over-allotment option      
Related Party Transaction [Line Items]      
Number of units sold | shares 191,102    
Exercise price of warrants | $ / shares $ 6.765    
Number of warrant purchase | Warrant 104,065    
Terms of common stock warrant 3 years    
Number of purchase common stock shares | shares 191,102    
Percentage Of Underwriting Discounts And Commissions 8.00%    
Offering price, per unit | $ / shares $ 6.15    
Series A or Series B Common Stock Purchase Warrant      
Related Party Transaction [Line Items]      
Exercise price of warrants | $ / shares   $ 16.00  
Stock purchase agreement | Series A or Series B Common Stock Purchase Warrant      
Related Party Transaction [Line Items]      
Warrant intrinsic value | $   $ 0  
Stock purchase agreement | Series A or Series B Common Stock Purchase Warrant | Minimum      
Related Party Transaction [Line Items]      
Exercise price of warrants | $ / shares   $ 8.00  
Stock purchase agreement | Series A or Series B Common Stock Purchase Warrant | Maximum      
Related Party Transaction [Line Items]      
Exercise price of warrants | $ / shares   $ 14.00  
NEOMED      
Related Party Transaction [Line Items]      
Number of units sold | shares     72,660
Number of issuance of common shares | shares     61,297
Value for issuance of common shares | $     $ 539,417
Shares issued for settlement of accrued liability | shares     11,363
Value for shares issued for settlement of accrued liability | $     $ 100,000